Phio Pharmaceuticals
Company Snapshot
Founded: 2011
Entity Type: Public
Employees: 6
Region: U.S.
Headquarter: Massachusetts, U.S.
Key Geographics: North America
Corporate Address: 11 Apex Drive Suite 300APMB 2006 Marlborough Massachusetts 01752 U.S. Tel. +1-(508)-767-3861 www.phiopharma.com
Company Overview
Phio Pharmaceuticals is focused on the application of RNAi therapies via Intasyl, its proprietary technology, to immuno-oncology therapeutics. It is a clinical stage pharmaceutical and biotechnology company.
Intasyl helps in the delivery of RNAi molecules directly into the cells. It is co-founded by Craig Mello, who received the Nobel Prize for his discovery of RNAi technology.
Phio Pharmaceuticals In Reports
Phio Pharmaceuticals In News
Company's Business Segments
- RNAi Therapies : The company develops therapeutics utilizing their INTASYL siRNA gene silencing technology, aimed at enhancing immune cells' effectiveness in fighting cancer cells.
Applications/End User Industries
- Biotechnology
- Pharmaceutical
- Life Sciences